Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-13
2011-11-01
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08048870
ABSTRACT:
The present invention describes chemotherapeutic compositions, a method for making the same, and methods for inducing apoptosis in tumor cells and/or inhibiting tumors. The compositions are metal coordination complexes of a cytotoxic metal, such as silver(I) and a chiral α-organic acid, such as tartaric acid, in a pharmaceutical carrier.
REFERENCES:
patent: 4708864 (1987-11-01), Maurer
patent: 4915955 (1990-04-01), Gomori
patent: 5348950 (1994-09-01), Hata et al.
patent: 5504055 (1996-04-01), Hsu
patent: 6280959 (2001-08-01), Gleason et al.
patent: 6329497 (2001-12-01), Boger
patent: 2002/0136780 (2002-09-01), Batarseh
patent: 2003/0147970 (2003-08-01), Newman et al.
patent: 2004/0191329 (2004-09-01), Burrell et al.
patent: 07-138167 (1995-05-01), None
patent: WO 00/62618 (2000-10-01), None
Coyle et al ‘Synthesis, X-ray crystal structure, anti-fungal and anti-cancer activity of [Ag2(NH3)2(salH)2] (salH2 = salicyclic acid)’ Journal of Inorganic Biochemistry, vol. 98, p. 1361-1366, 2004.
Strickley ‘Solubilizing Excipients in Oral and Injectable Formulations’ Pharmaceutical Research, vol. 21(2), p. 201-229, 2004.
Bott et al ‘Univalent Metal Ion Alpha-Hydroxy Acid Interactions: Part 9. Preparation and Crystal Structures of Lithium Hydrogen (+)-Tartrate monohydrate, Potassium (+)-Tartrate Hemihydrate and Thallium(I) (+)-Tartrate’ Polyhedron, 13(22), pp. 3135-3141, 1994.
Bott et al ‘Structures of hydrogen (+)-tartrates of sodium, thallium(I) and silver(I)’ Zeitschrift fur Kristallographie, vol. 209, p. 803-807, 1994.
Batarseh, “Anomaly and correlation of killing in the therapeutic properties of silver (I)-chelation with glutamic and tartaric acids,” Journal of Anticibrobial Chemotherapy, vol. 54, No. 2, 2004, pp. 546-548.
Farrell, “Metal Complexes as Drugs and Chemotherapeutic Agents,” Kluwer Academic Publishers (Dordrecht and Boston), vol. 11, 1989, pp. 809-840.
International Search Report and Written Opinion of the International Searching Authority for PCT/US06/000390 dated Jul. 27, 2007.
Supplementary European Search Report for corresponding European Patent Application No. 06 71 7569 dated Nov. 20, 2009 (8 pages).
Gil et al., “Carboxilatos hidroxilados de rodio II (gluconato, lactobionato y lactato). Síntesis, caracterización y ensayos de actividad citostática in vitro,” Anales De La Real Academia De Farmacia, vol. 66, No. 2, Jan. 1, 2000, pp. 229-239, (see English Summary on pp. 229-230) (11 pages).
Fetterolf Brandon
Stone Christopher R
LandOfFree
Apoptosis-inducing antineoplastic silver (I) coordination... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apoptosis-inducing antineoplastic silver (I) coordination..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptosis-inducing antineoplastic silver (I) coordination... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4296986